The purpose of the Flow Cytometry and Functional Immunology Research Core is to provide a centralizedresource of technical expertise and major equipment to support and enhance the experimental design andexecution of basic and clinical research in HIV pathogenesis that require application of flow cytometricphenotypic analysis, cell sorting, and/or evaluation of specific immune cell functions. A prime goal is toprovide the intellectual environment and the material resources to enable junior investigators to apply flowcytometry technology to their projects and to encourage established investigators to initiate innovative pilotstudies. To achieve these objectives, expert consultation is provided through the Core Director, AssociateDirectors, and technical supervisor; major instruments are selected for complementary functions;equipment use is accessible through dedicated technician operators; services are provided on a rechargebasis; generated data are analyzed, reduced, and diagramed; and fiscal support is given to pilot andexploratory research projects through the provision of research reagents and instrument time. CFARresources have enabled the Core to support a wide array of HIV research encompassing basic projects onviral regulation and mechanisms of pathogenesis to preclinical development of vaccines and genetherapies, and clinical studies of primary infection, opportunistic infections, neurobiology, and immune andviral responses to vaccines and HAART.To maintain our flow cytometry facility to meet the needs of the San Diego academic research community,several funding sources have been integrated for cooperative support: the UCSD Center for AIDSResearch (CFAR), the VA Research Center for AIDS and HIV Infection (RCAHI), and the Veterans AffairsMedical Research Foundation (VMRF). In addition to principal investigators based at UCSD and the VAMedical Center, investigators from The Scripps Research Institute, the Salk Institute, the La Jolla Instituteof Allergy and Immunology, and the Burnham Institute also utilize the resources provided by our centralfacility. Local use of flow cytometric technology continues to grow and diversify, and the Core facility strivesto keep up with the growing demand. The CFAR award remains an integral component in this endeavor.Application of flow cytometry to several areas of biomolecular research, in addition to expandedapplications in clinical research, makes continued CFAR support crucial to providing the infrastructure totake advantage of new scientific opportunities in HIV research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-15
Application #
7635795
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2008-06-01
Project End
2012-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
15
Fiscal Year
2008
Total Cost
$384,286
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Arredondo, J; Gaines, T; Manian, S et al. (2018) The law on the streets: Evaluating the impact of Mexico's drug decriminalization reform on drug possession arrests in Tijuana, Mexico. Int J Drug Policy 54:1-8
Hoenigl, Martin; Orasch, Thomas; Faserl, Klaus et al. (2018) Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis. J Infect :
Howe, Chanelle J; Dulin-Keita, Akilah; Cole, Stephen R et al. (2018) Evaluating the Population Impact on Racial/Ethnic Disparities in HIV in Adulthood of Intervening on Specific Targets: A Conceptual and Methodological Framework. Am J Epidemiol 187:316-325
Bortell, Nikki; Basova, Liana; Najera, Julia A et al. (2018) Sirtuin 1-Chromatin-Binding Dynamics Points to a Common Mechanism Regulating Inflammatory Targets in SIV Infection and in the Aging Brain. J Neuroimmune Pharmacol 13:163-178
Ward, Zoe; Platt, Lucy; Sweeney, Sedona et al. (2018) Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets? Addiction :
Moore, David J; Jain, Sonia; Dubé, Michael P et al. (2018) Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study. Clin Infect Dis 66:1566-1572
Cachay, Edward R; Agmas, Wollelaw; Christopher Mathews, Wm (2018) Disparities in the Clinical Evolution of Anal Neoplasia in an HIV-Infected Cohort. J Racial Ethn Health Disparities 5:209-212
Pines, H A; Strathdee, S A; Hendrix, C W et al. (2018) Oral and vaginal HIV pre-exposure prophylaxis product attribute preferences among female sex workers in the Mexico-US border region. Int J STD AIDS :956462418793038
Burlacu, Ruxandra; Umlauf, Anya; Luca, Anca et al. (2018) Sex-based differences in neurocognitive functioning in HIV-infected young adults. AIDS 32:217-225
Pines, Heather A; Semple, Shirley J; Strathdee, Steffanie A et al. (2018) Vaginal washing and lubrication among female sex workers in the Mexico-US border region: implications for the development of vaginal PrEP for HIV prevention. BMC Public Health 18:1009

Showing the most recent 10 out of 921 publications